Paramyxovirus fusion (F) protein and hemagglutinin-neuraminidase (HN) protein interactions: Intracellular retention of F and HN does not affect transport of the homotypic HN or F protein

Virology

Volumn 237, Issue 1, 1997, Pages 1-9

  Paterson, Reay G ^a   Johnson, Michael L ^a   Lamb, Robert A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; HYBRID PROTEIN; SIALIDASE;

ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PARAINFLUENZA VIRUS 3; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT;

HUMAN PARAINFLUENZA VIRUS 3; MAMMALIA; PARAMYXOVIRIDAE; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5; SIMIAN VIRUS;

EID: 0030680910     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8759     Document Type: Article

References (47)

1. Bagai S., Lamb R. A. Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:1995;6712-6719.
2. Bagai S., Lamb R. A. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 135:1996;73-84.
3. Bousse T., Takimoto T., Murti K. G., Portner A. Elevated expression of the human parainfluenza virus type 1 F gene down regulates HN expression. Virology. 232:1997;44-52.
4. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
5. Buonocore L., Rose J. K. Prevention of HIV-1 glycopotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 345:1990;625-628.
6. Carr C. M., Kim P. S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
7. Cattaneo R., Rose J. K. Cell fusion by the envelope glycoproteins of persistent measles viruses which cause lethal human brain disease. J. Virol. 67:1993;1493-1502.
8. Coelingh K. L. V., Winter C. C., Jorgensen E. D., Murphy B. R. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: Sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J. Virol. 61:1987;1473-1477.
9. Coelingh K. V., Tierney E. L. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J. Virol. 63:1989;375-382.
10. Deng R., Wang Z., Mirza A. M., Iorio R. M. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology. 209:1995;457-469.
11. Deng W. P., Nickoloff J. A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:1992;81-88.
12. Doms R. W., Lamb R. A., Rose J. K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 193:1993;545-562.
13. Ebata S. N., Cote M. J., Kang C. Y., Dimock K. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology. 183:1991;437-441.
14. 7. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
15. Galinski M. S., Mink M. A., Pons M. W. Molecular cloning and sequence analysis of the human parainfluenza 3 virus genes encoding the surface glycoproteins, F and HN. Virus Res. 8:1987;205-215.
16. Hiebert S. W., Paterson R. G., Lamb R. A. Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J. Virol. 55:1985;744-751.
17. Horvath C. M., Lamb R. A. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion. J. Virol. 66:1992;2443-2455.
18. Horvath C. M., Paterson R. G., Shaughnessy M. A., Wood R., Lamb R. A. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia. J. Virol. 66:1992;4564-4569.
19. Hu X., Ray R., Compans R. W. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol. 66:1992;1528-1534.
20. Jackson M. R., Nilsson T., Peterson P. A. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9:1990;3153-3162.
21. Lamb R. A. Paramyxovirus fusion: A hypothesis for changes. Virology. 197:1993;1-11.
22. Lamb R. A., Etkind P. R., Choppin P. W. Evidence for a ninth influenza viral polypeptide. Virology. 91:1978;60-78.
23. Malvoisin E., Wild T. F. Measles virus glycoproteins: Studies on the structure and interaction of the haemagglutinin and fusion proteins. J. Gen. Virol. 74:1993;2365-2372.
24. Morrison T., McQuain C., McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: Requirements for membrane fusion. J. Virol. 65:1991;813-822.
25. Munro S., Pelham H. R. B. A C-terminal signal prevents secretion of luminal ER proteins. Cell. 48:1987;899-907.
26. Nilsson I., Whitley P., von Heijne G. The COOH-terminal ends of internal signal and signal-anchor sequences are positioned differently in the ER translocase. J. Cell. Biol. 126:1994;1127-1132.
27. Paterson R. G., Harris T. J. R., Lamb R. A. Fusion protein of the paramyxovirus simian virus 5: Nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc. Natl. Acad. Sci. USA. 81:1984;6706-6710.
28. Paterson R. G., Hiebert S. W., Lamb R. A. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc. Natl. Acad. Sci. USA. 82:1985;7520-7524.
29. Paterson R. G., Lamb R. A. Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor. Cell. 48:1987;441-452.
30. Paterson R. G., Lamb R. A. The molecular biology of influenza viruses and paramyxoviruses. Molecular Virology: A Practical Approach. 1993;IRL Oxford Univ. Press, Oxford. p. 35-73.
31. Paterson R. G., Shaughnessy M. A., Lamb R. A. Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J. Virol. 63:1989;1293-1301.
32. Randall R. E., Young D. F., Goswami K. K. A., Russell W. C. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68:1987;2769-2780.
33. Rose J. K., Buonocore L., Whitt M. A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechnology. 10:1991;520-525.
34. Russell R., Paterson R. G., Lamb R. A. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology. 199:1994;160-168.
35. 2. J. Cell Biol. 133:1996;733-747.
36. Sakai Y., Shibuta H. Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J. Virol. 63:1989;3661-3668.
37. Schutze M.-P., Peterson P. A., Jackson M. R. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J. 13:1994;1696-1705.
38. Sergel T., McGinnes L. W., Peeples M. E., Morrison T. G. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology. 193:1993;717-726.
39. Skehel J. J., Bayley P. M., Brown E. B., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA. 79:1982;968-972.
40. Tanabayashi K., Compans R. W. Functional interaction of paramyxovirus glycoproteins: Identification of a domain in Sendai virus HN which promotes cell fusion. J. Virol. 70:1996;6112-6118.
41. Tanabayashi K., Takeuchi K., Okazaki K., Hishiyama M., Yamada A. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: Both F and HN proteins are required for cell fusion. Virology. 187:1992;801-804.
42. Tanaka Y., Heminway B. R., Galinski M. S. Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum. J. Virol. 70:1996;5005-5015.
43. Taylor J., Pincus S., Tartaglia J., Richardson C., Alkhatib G., Briedis D., Appel M., Norton E., Paoletti E. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. J. Virol. 65:1991;4263-4274.
44. Tsurodome M., Kawano M., Yuasa T., Tabata N., Nishimo M., Komada H., Ito Y. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology. 213:1995;190-203.
45. Ward C. D., Paterson R. G., Lamb R. A. Mutants of the paramyxovirus SV5 fusion protein: Regulated and extensive syncytium formation. Virology. 209:1995;242-249.
46. Wild T. F., Malvoisin E., Buckland R. Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72:1991;439-442.
47. Yao Q., Hu X., Compans R. W. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J. Virol. 71:1997;650-656.